GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Standard BioTools Inc (STU:FLB) » Definitions » Cyclically Adjusted Book per Share

Standard BioTools (STU:FLB) Cyclically Adjusted Book per Share : €2.03 (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Standard BioTools Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Standard BioTools's adjusted book value per share for the three months ended in Mar. 2024 was €1.396. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €2.03 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Standard BioTools's average Cyclically Adjusted Book Growth Rate was -19.90% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -9.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Standard BioTools was 1.30% per year. The lowest was -9.70% per year. And the median was -4.20% per year.

As of today (2024-05-28), Standard BioTools's current stock price is €2.30. Standard BioTools's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €2.03. Standard BioTools's Cyclically Adjusted PB Ratio of today is 1.13.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Standard BioTools was 3.15. The lowest was 0.33. And the median was 1.10.


Standard BioTools Cyclically Adjusted Book per Share Historical Data

The historical data trend for Standard BioTools's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Standard BioTools Cyclically Adjusted Book per Share Chart

Standard BioTools Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.39 2.72 2.63 2.76 2.20

Standard BioTools Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.51 2.42 2.35 2.20 2.03

Competitive Comparison of Standard BioTools's Cyclically Adjusted Book per Share

For the Diagnostics & Research subindustry, Standard BioTools's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Standard BioTools's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Standard BioTools's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Standard BioTools's Cyclically Adjusted PB Ratio falls into.



Standard BioTools Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Standard BioTools's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.396/131.7762*131.7762
=1.396

Current CPI (Mar. 2024) = 131.7762.

Standard BioTools Quarterly Data

Book Value per Share CPI Adj_Book
201406 4.230 100.560 5.543
201409 4.248 100.428 5.574
201412 4.304 99.070 5.725
201503 4.584 99.621 6.064
201506 4.110 100.684 5.379
201509 3.842 100.392 5.043
201512 3.657 99.792 4.829
201603 3.076 100.470 4.034
201606 2.583 101.688 3.347
201609 2.080 101.861 2.691
201612 1.728 101.863 2.235
201703 1.229 102.862 1.574
201706 0.724 103.349 0.923
201709 0.849 104.136 1.074
201712 0.674 104.011 0.854
201803 1.012 105.290 1.267
201806 0.762 106.317 0.944
201809 0.489 106.507 0.605
201812 1.285 105.998 1.598
201903 2.338 107.251 2.873
201906 2.202 108.070 2.685
201909 2.123 108.329 2.583
201912 1.976 108.420 2.402
202003 1.811 108.902 2.191
202006 1.653 108.767 2.003
202009 1.741 109.815 2.089
202012 1.533 109.897 1.838
202103 1.378 111.754 1.625
202106 1.193 114.631 1.371
202109 1.104 115.734 1.257
202112 1.088 117.630 1.219
202203 0.260 121.301 0.282
202206 -0.450 125.017 -0.474
202209 -0.800 125.227 -0.842
202212 -0.968 125.222 -1.019
202303 -1.154 127.348 -1.194
202306 -1.323 128.729 -1.354
202309 -1.553 129.860 -1.576
202312 -1.692 129.419 -1.723
202403 1.396 131.776 1.396

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Standard BioTools  (STU:FLB) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Standard BioTools's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=2.30/2.03
=1.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Standard BioTools was 3.15. The lowest was 0.33. And the median was 1.10.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Standard BioTools Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Standard BioTools's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Standard BioTools (STU:FLB) Business Description

Traded in Other Exchanges
Address
2 Tower Place, Suite 2000, South San Francisco, CA, USA, 94080
Standard BioTools Inc manufactures life science tools focused on the analysis of single cells and industrial applications of genomics. The company's segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.

Standard BioTools (STU:FLB) Headlines

No Headlines